Literature DB >> 17982329

Combined oral contraceptives: a comprehensive review.

Jessica Kiley1, Cassing Hammond.   

Abstract

Millions of women use birth control pills for contraceptive and noncontraceptive reasons. Although there have been reports of rare adverse events, birth control pills do offer well-documented health benefits, including a decrease in the risk of ovarian and endometrial carcinoma. In addition, manufacturers continue to modify birth control pills to reduce side effects and medical risks.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17982329     DOI： 10.1097/GRF.0b013e318159c06a

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


  13 in total

1.  Oral contraceptive use among women in the military and the general U.S. population.

Authors:  Lindsey Enewold; Louise A Brinton; Katherine A McGlynn; Shelia H Zahm; John F Potter; Kangmin Zhu
Journal:  J Womens Health (Larchmt)       Date:  2010-05       Impact factor: 2.681

2.  Effects of hormonally active agents on steroid hormone receptor expression and cell proliferation in the myometrium of ovariectomized macaques.

Authors:  Georgette D Hill; Alicia B Moore; Grace E Kissling; Norris D Flagler; Elizabeth Ney; J Mark Cline; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2011-03-16       Impact factor: 1.902

3.  Pre-gravid oral contraceptive use in relation to birth weight: a prospective cohort study.

Authors:  Elizabeth E Hatch; Kristen A Hahn; Ellen M Mikkelsen; Anders H Riis; Henrik Toft Sorensen; Kenneth J Rothman; Lauren A Wise
Journal:  Eur J Epidemiol       Date:  2015-06-16       Impact factor: 8.082

4.  Risk factors for developing endometrial cancer after benign endometrial sampling.

Authors:  Michelle L Torres; Amy L Weaver; Sanjeev Kumar; Stefano Uccella; Abimbola O Famuyide; William A Cliby; Sean C Dowdy; Bobbie S Gostout; Andrea Mariani
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

5.  The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg.

Authors:  Sheila Krishnan; Jessica Kiley
Journal:  Int J Womens Health       Date:  2010-08-10

6.  Estradiol valerate and dienogest: a new approach to oral contraception.

Authors:  Jessica W Kiley; Lee P Shulman
Journal:  Int J Womens Health       Date:  2011-08-18

7.  Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar; James Mn Duffy
Journal:  Cochrane Database Syst Rev       Date:  2020-07-23

8.  Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Timothy R Rebbeck; Susan M Domchek
Journal:  Breast Cancer Res       Date:  2008-07-25       Impact factor: 6.466

9.  "Every method seems to have its problems"- Perspectives on side effects of hormonal contraceptives in Morogoro Region, Tanzania.

Authors:  Joy J Chebet; Shannon A McMahon; Jesse A Greenspan; Idda H Mosha; Jennifer A Callaghan-Koru; Japhet Killewo; Abdullah H Baqui; Peter J Winch
Journal:  BMC Womens Health       Date:  2015-11-03       Impact factor: 2.809

10.  Biological variability and impact of oral contraceptives on vitamins B(6), B(12) and folate status in women of reproductive age.

Authors:  Jennifer O McArthur; HoMan Tang; Peter Petocz; Samir Samman
Journal:  Nutrients       Date:  2013-09-16       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.